PUBLISHER: 360iResearch | PRODUCT CODE: 1589793
PUBLISHER: 360iResearch | PRODUCT CODE: 1589793
Epinephrine Auto-Injector Market by Dosage (0.3 Mg Epinephrine Autoinjector, 0.5 Mg Epinephrine Autoinjector, Mg Epinephrine Autoinjector), End-User (Clinics, Hospital, Individual) - Global Forecast 2025-2030
The Epinephrine Auto-Injector Market was valued at USD 351.01 million in 2023, expected to reach USD 384.83 million in 2024, and is projected to grow at a CAGR of 9.73%, to USD 672.40 million by 2030.
The epinephrine auto-injector market encompasses devices designed for the swift delivery of epinephrine, particularly in life-threatening allergic reactions known as anaphylaxis, often triggered by foods, insect stings, or other allergens. The necessity of these auto-injectors arises from their ability to deliver a precise and rapid dose of epinephrine, which is vital in counteracting severe allergic responses, offering critical intervention until medical assistance is available. The market's application spans across healthcare facilities, educational institutions, and domestic environments, with end-users including individuals with diagnosed allergies and healthcare providers. The growth of this market is primarily influenced by the rising incidence of food allergies and increasing government regulations mandating schools to have these devices on hand, alongside heightened consumer awareness. Furthermore, potential opportunities can be seen in the development of user-friendly designs, innovative training technologies, and improved cost-effectiveness, coupled with expanding market access in emerging economies. Challenges restraining market growth include high product costs, regulatory hurdles, and limited access to injectors in some regions due to distribution inefficiencies. Additionally, recalls and technical malfunctions can impact consumer trust and adoption rates. Innovations focusing on enhancing injector reliability, portability, and digital connectivity through smart medical devices can pave the way for significant advancements within the market. Exploring research into alternative delivery mechanisms or formulations of epinephrine can further present new growth avenues. Sustainability and eco-friendly disposal options might also create new opportunities in line with global environmental goals. Despite market challenges, the nature of the epinephrine auto-injector market remains resilient, driven by essential healthcare needs and persistently growing customer demand for safe, effective, and readily accessible emergency medical solutions.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 351.01 million |
| Estimated Year [2024] | USD 384.83 million |
| Forecast Year [2030] | USD 672.40 million |
| CAGR (%) | 9.73% |
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Epinephrine Auto-Injector Market
The Epinephrine Auto-Injector Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Growing awareness about allergies
- Technological developments in research & development activities
- High demand for autoinjectors instead of conventional devices such as standard syringes
- Market Restraints
- High cost of epinephrine auto injector
- Market Opportunities
- Demand for easy usability of disposable drug injectors
- Increasing adoption self-management of anaphylaxis
- Market Challenges
- Stringent regulations imposed by the government
Porter's Five Forces: A Strategic Tool for Navigating the Epinephrine Auto-Injector Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Epinephrine Auto-Injector Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Epinephrine Auto-Injector Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Epinephrine Auto-Injector Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Epinephrine Auto-Injector Market
A detailed market share analysis in the Epinephrine Auto-Injector Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Epinephrine Auto-Injector Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Epinephrine Auto-Injector Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Epinephrine Auto-Injector Market
A strategic analysis of the Epinephrine Auto-Injector Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Epinephrine Auto-Injector Market, highlighting leading vendors and their innovative profiles. These include ALK-Abello A/S, Amgen Inc., Amneal Pharmaceuticals Inc., Antares Pharma Inc. by Halozyme Therapeutics, Inc., Bausch Health Companies, Inc., Becton, Dickinson and Company, Eli Lilly and Company, Kaleo, Inc., Lincoln Medical Centre Ltd., Merck KGaA, Pfizer, Inc., Sanofi SA, Shionogi Pharma, Inc., Teva Pharmaceuticals Ltd., and Viatris.
Market Segmentation & Coverage
This research report categorizes the Epinephrine Auto-Injector Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Dosage, market is studied across 0.3 Mg Epinephrine Autoinjector, 0.5 Mg Epinephrine Autoinjector, and Mg Epinephrine Autoinjector.
- Based on End-User, market is studied across Clinics, Hospital, and Individual.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing awareness about allergies
- 5.1.1.2. Technological developments in research & development activities
- 5.1.1.3. High demand for autoinjectors instead of conventional devices such as standard syringes
- 5.1.2. Restraints
- 5.1.2.1. High cost of epinephrine auto injector
- 5.1.3. Opportunities
- 5.1.3.1. Demand for easy usability of disposable drug injectors
- 5.1.3.2. Increasing adoption self-management of anaphylaxis
- 5.1.4. Challenges
- 5.1.4.1. Stringent regulations imposed by the government
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Epinephrine Auto-Injector Market, by Dosage
- 6.1. Introduction
- 6.2. 0.3 Mg Epinephrine Autoinjector
- 6.3. 0.5 Mg Epinephrine Autoinjector
- 6.4. Mg Epinephrine Autoinjector
7. Epinephrine Auto-Injector Market, by End-User
- 7.1. Introduction
- 7.2. Clinics
- 7.3. Hospital
- 7.4. Individual
8. Americas Epinephrine Auto-Injector Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
9. Asia-Pacific Epinephrine Auto-Injector Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
10. Europe, Middle East & Africa Epinephrine Auto-Injector Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
11. Competitive Landscape
- 11.1. Market Share Analysis, 2023
- 11.2. FPNV Positioning Matrix, 2023
- 11.3. Competitive Scenario Analysis
- 11.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. ALK-Abello A/S
- 2. Amgen Inc.
- 3. Amneal Pharmaceuticals Inc.
- 4. Antares Pharma Inc. by Halozyme Therapeutics, Inc.
- 5. Bausch Health Companies, Inc.
- 6. Becton, Dickinson and Company
- 7. Eli Lilly and Company
- 8. Kaleo, Inc.
- 9. Lincoln Medical Centre Ltd.
- 10. Merck KGaA
- 11. Pfizer, Inc.
- 12. Sanofi SA
- 13. Shionogi Pharma, Inc.
- 14. Teva Pharmaceuticals Ltd.
- 15. Viatris
LIST OF FIGURES
- FIGURE 1. EPINEPHRINE AUTO-INJECTOR MARKET RESEARCH PROCESS
- FIGURE 2. EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 11. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 13. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 15. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. EPINEPHRINE AUTO-INJECTOR MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 19. EPINEPHRINE AUTO-INJECTOR MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. EPINEPHRINE AUTO-INJECTOR MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. EPINEPHRINE AUTO-INJECTOR MARKET DYNAMICS
- TABLE 7. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.3 MG EPINEPHRINE AUTOINJECTOR, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.5 MG EPINEPHRINE AUTOINJECTOR, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY MG EPINEPHRINE AUTOINJECTOR, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY INDIVIDUAL, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 16. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 17. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 18. ARGENTINA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 19. ARGENTINA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 20. BRAZIL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 21. BRAZIL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 22. CANADA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 23. CANADA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 24. MEXICO EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 25. MEXICO EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 26. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 27. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 28. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 29. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 30. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 31. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 32. AUSTRALIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 33. AUSTRALIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 34. CHINA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 35. CHINA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 36. INDIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 37. INDIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 38. INDONESIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 39. INDONESIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 40. JAPAN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 41. JAPAN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 42. MALAYSIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 43. MALAYSIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 44. PHILIPPINES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 45. PHILIPPINES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 46. SINGAPORE EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 47. SINGAPORE EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 48. SOUTH KOREA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 49. SOUTH KOREA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 50. TAIWAN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 51. TAIWAN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 52. THAILAND EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 53. THAILAND EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 54. VIETNAM EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 55. VIETNAM EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 56. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 57. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 58. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 59. DENMARK EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 60. DENMARK EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 61. EGYPT EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 62. EGYPT EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 63. FINLAND EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 64. FINLAND EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 65. FRANCE EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 66. FRANCE EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 67. GERMANY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 68. GERMANY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 69. ISRAEL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 70. ISRAEL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 71. ITALY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 72. ITALY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 73. NETHERLANDS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 74. NETHERLANDS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 75. NIGERIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 76. NIGERIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 77. NORWAY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 78. NORWAY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 79. POLAND EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 80. POLAND EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 81. QATAR EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 82. QATAR EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 83. RUSSIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 84. RUSSIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 85. SAUDI ARABIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 86. SAUDI ARABIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 87. SOUTH AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 88. SOUTH AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 89. SPAIN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 90. SPAIN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 91. SWEDEN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 92. SWEDEN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 93. SWITZERLAND EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 94. SWITZERLAND EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 95. TURKEY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 96. TURKEY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 97. UNITED ARAB EMIRATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 98. UNITED ARAB EMIRATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 99. UNITED KINGDOM EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
- TABLE 100. UNITED KINGDOM EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 101. EPINEPHRINE AUTO-INJECTOR MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 102. EPINEPHRINE AUTO-INJECTOR MARKET, FPNV POSITIONING MATRIX, 2023
